Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women

被引:47
作者
Korhonen, T
Savolainen, MJ
Koistinen, MJ
Ikaheimo, M
Linnaluoto, MK
Kervinen, K
Kesaniemi, YA
机构
[1] UNIV OULU, DEPT INTERNAL MED, FIN-90220 OULU, FINLAND
[2] UNIV OULU, BIOCTR OULU, FIN-90220 OULU, FINLAND
基金
芬兰科学院;
关键词
apolipoprotein E; coronary stenosis; female; male; plasma lipids;
D O I
10.1016/S0021-9150(96)05958-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The differences between the lipid profiles of male and female patients and the effect of plasma lipids on the extent of coronary artery disease were evaluated in 122 angiographically assessed coronary artery disease patients (95 males and 27 females) and 60 controls. Both male and female patients had lower HDL-cholesterol and higher total cholesterol, LDL-cholesterol, triglyceride, VLDL-cholesterol and VLDL-triglyceride concentrations than the controls. The VLDL lipid values did not differ significantly between the male patients with different extent of CAD, whereas the VLDL lipid values of female patients tended to increase with an increasing severity of CAD. High Lp(a) (greater than or equal to 35 mg/dl) values were more prevalent in patients with > 50% coronary stenosis compared to patients with < 50% stenosis and the controls (29%, 17% and 12%, respectively). The apolipoprotein E phenotypes and epsilon allele frequencies were similar in the patients and the controls. Low HDL-cholesterol and high LDL-cholesterol are CAD risk factors for both sexes. For women, elevated VLDL-triglycerides seem to be an additional risk factor for CAD.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 48 条
[1]   THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS [J].
ARMSTRONG, VW ;
CREMER, P ;
EBERLE, E ;
MANKE, A ;
SCHULZE, F ;
WIELAND, H ;
KREUZER, H ;
SEIDEL, D .
ATHEROSCLEROSIS, 1986, 62 (03) :249-257
[2]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[3]   DOSE-RESPONSE RELATIONSHIPS OF SERUM-LIPID MEASUREMENTS WITH THE EXTENT OF CORONARY STENOSIS - STRONG, INDEPENDENT, AND COMPREHENSIVE [J].
BOLIBAR, I ;
THOMPSON, SG ;
VONECKARDSTEIN, A ;
SANDKAMP, M ;
ASSMANN, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (08) :1035-1042
[4]   15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J].
CANNER, PL ;
BERGE, KG ;
WENGER, NK ;
STAMLER, J ;
FRIEDMAN, L ;
PRINEAS, RJ ;
FRIEDEWALD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) :1245-1255
[5]  
COHN P, 1989, SILENT MYOCARDIAL IS
[6]  
CORESH J, 1993, J LIPID RES, V34, P1687
[7]   PLASMA TRIGLYCERIDE LEVEL AND MORTALITY FROM CORONARY HEART-DISEASE [J].
CRIQUI, MH ;
HEISS, G ;
COHN, R ;
COWAN, LD ;
SUCHINDRAN, CM ;
BANGDIWALA, S ;
KRITCHEVSKY, S ;
JACOBS, DR ;
OGRADY, HK ;
DAVIS, CE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1220-1225
[8]  
CUMMING AM, 1984, CLIN GENET, V25, P310
[9]  
DAHLEN G, 1975, CLIN GENET, V7, P334
[10]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765